PartnerRe Asset Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-2,703
Closed -$724K 453
2016
Q1
$724K Buy
2,703
+100
+4% +$28.6K 0.37% 43
2015
Q4
$813K Sell
2,603
-4,486
-63% -$1.34M 0.42% 38
2015
Q3
$1.93M Hold
7,089
0.33% 51
2015
Q2
$2.15M Sell
7,089
-1,184
-14% -$353K 0.4% 48
2015
Q1
$2.46M Buy
8,273
+2,628
+47% +$749K 0.41% 47
2014
Q4
$1.45M Buy
5,645
+804
+17% +$201K 0.24% 76
2014
Q3
$1.17M Sell
4,841
-789
-14% -$177K 0.23% 80
2014
Q2
$1.26M Buy
+5,630
New +$1.17M 0.22% 91
2014
Q1
Sell
-4,190
Closed -$704K 522
2013
Q4
$704K Buy
4,190
+796
+23% +$124K 0.12% 155
2013
Q3
$489K Sell
3,394
-292
-8% -$38.9K 0.08% 207
2013
Q2
$465K Buy
+3,686
New +$417K 0.08% 231

Other funds holding AGN

PartnerRe Asset Management's AGN Position: Q2 2016 in Review

PartnerRe Asset Management sold out of Allergan plc (AGN) in Q2 2016, closing a stake of 2,703 shares — an estimated $724K sold.

PartnerRe Asset Management first reported a position in AGN in Q2 2013 and held it in 11 quarters. The position peaked at $2.46M in Q1 2015. 1,107 funds tracked by Wall St. Rank hold AGN as of Q2 2016.

  • PartnerRe Asset Management reported no remaining Allergan plc position as of Q2 2016 after selling out during the quarter.
  • PartnerRe Asset Management sold 2,703 Allergan plc shares in Q2 2016, an estimated $724K.
  • PartnerRe Asset Management first reported a position in Allergan plc in Q2 2013 and held it in 11 quarters.
  • PartnerRe Asset Management's Allergan plc position peaked at $2.46M in Q1 2015.
  • 1,107 funds tracked by Wall St. Rank held Allergan plc as of Q2 2016.

Based on PartnerRe Asset Management's 13F filing for Q2 2016, filed 14 Jul 2016.